SATRALIZUMAB | B761149 | GENENTECH
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Aug. 14, 2032 | Active | Computed |
| 7-Year Orphan | Aug. 14, 2027 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12391769(manufacturing) · relevance 70/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 173 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.